We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Detecto

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
16 Feb 2023 - 18 Feb 2023

Disruptive Surgical Robotic System Offers Less Pain, Faster Recovery and Fewer Scars

By HospiMedica International staff writers
Posted on 12 Aug 2022
Print article
Image: The Levita MARS platform is designed to make robotic surgery accessible for all (Photo courtesy of Levita Magnetics)
Image: The Levita MARS platform is designed to make robotic surgery accessible for all (Photo courtesy of Levita Magnetics)

A new robotic platform is designed to deliver clinical benefits such as less pain, faster recovery and fewer scars for patients undergoing abdominal surgeries.

The Magnetic-Assisted Robotic Surgery (MARS) platform from Levita Magnetics (Menlo Park, CA, USA) is designed to improve the efficiency and quality of procedures in high-volume abdominal surgeries, improving surgical access to patients and enabling a less invasive approach with fewer incisions, while allowing the surgeon full control of the platform and surgical instruments directly beside the patient. The MARS platform is intended to improve visualization, maintain surgeon control of instruments, and increase hospital efficiency with fewer assistive personnel required to conduct the procedures.

With its compact footprint, the new robotic platform is designed for outpatient or same-day discharge procedures in high-volume abdominal surgeries. MARS aims to increase the volume of high-quality, efficiently performed procedures while increasing access by making robotic surgery available across the care spectrum – from community to academic centers and by improving the patient experience. The MARS Platform is an investigational system. It is not available for commercial sale in the US and has not been cleared by the Food and Drug Administration (FDA).

“At Levita, we believe that everyone deserves the benefits of MARS, offering the potential for less pain, faster recovery, and less scarring. Our platform is poised to address the worldwide problem of limited access to better robotic surgery,” said Dr. Alberto Rodriguez-Navarro, surgeon, founder and CEO of Levita Magnetics.

Related Links:
Levita Magnetics 

Gold Supplier
Temperature Monitor
ThermoScan Temperature Monitoring Unit
New
Smart nCPAP Device
SVAAS nCPAP
New
Radiography System
Riviera SPV
New
Mobile Radiography System
NeuVision 550M (Plus)

Print article

Channels

AI

view channel
Image: A novel research study moves the needle on predicting coronary artery disease (Photo courtesy of Pexels)

AI-Enabled ECG Analysis Predicts Heart Attack Risk Nearly as well as CT Scans

Increased coronary artery calcium is a marker of coronary artery disease that can lead to a heart attack. Traditionally, CT scans are used to diagnose buildup of coronary artery calcium, although CT scanners... Read more

Critical Care

view channel
Image: New spray fights infections and antibiotic resistance (Photo courtesy of Chalmers University of Technology)

Hydrogel-Based Spray Kills Antibiotic-Resistant Bacteria in Wounds and Biomedical Implants

Antibiotic resistance has been ranked among the top ten threats to global health by the World Health Organization (WHO). Antibiotic-resistant bacteria is estimated to cause almost 1.3 million deaths annually... Read more

Health IT

view channel
Image: Using digital data can improve health outcomes (Photo courtesy of Unsplash)

Electronic Health Records May Be Key to Improving Patient Care, Study Finds

When a patient gets transferred from a hospital to a nearby specialist or rehabilitation facility, it is often difficult for personnel at the new facility to access the patient’s electronic health records... Read more

Point of Care

view channel
Image: Steripath improves the diagnostic accuracy and timeliness of sepsis test results (Photo courtesy of Magnolia)

All-in-One Device Reduces False-Positive Diagnostic Test Results for Bloodstream Infections

Blood cultures are considered the gold standard diagnostic test for the detection of blood stream infections, such as sepsis. However, positive blood culture results can be frequently wrong, and about... Read more

Business

view channel
Image: The global endoscopy equipment market is projected to surpass USD 40 billion by 2027 (Photo courtesy of Pexels)

Global Endoscopy Equipment Market Driven by Growing Hospital Investment in Advanced Instruments

The global endoscopy equipment market is projected to register a CAGR of 7% from USD 28.9 billion in 2022 to USD 40.6 billion by 2027, driven by increasing demand for endoscopy to diagnose and treat target... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.